Newsroom
Preclinical Model to Guide Immunotherapeutic Development
Champions Oncology will be presenting data on it's preclinical model at the ongoing EORTC-NCI-AACR Symposium in Barcelona. The model proposes to help develop individualized treatments for patients.
The Argument For Better Patient-Centered Care in Oncology
After 4 years of living with inflammatory breast cancer, Amy Berman, RN, BS, senior program officer at the John A. Hartford Foundation, she still felt fine, which she attributed to her care choices, she explained during her speech at The American Journal of Managed Care’s Patient-Centered Oncology Care meeting in Baltimore, Maryland.
EASE—An App to Ease Family Anxiety During Surgery
A HIPAA-compliant app developed by doctors at the Arnold Palmer Hospital for Children in Orlando, helps quell the anxiety of family members as their children undergo surgery.
Study Identifies Disparities in Lung Cancer Treatment
The study, published in the Journal of Thoracic Oncology, identified race, insurance status, and the treatment center as variables that influenced treatment received by individuals with early-stage lung cancer.
ASCO Members Take a Stand on Access to Care for Low-Income Individuals
In a paper published in the Journal of Clinical Oncology, medical oncologists have delineated their recommendations to improve cancer care and provide better access to quality care for those patients with financial issues and on Medicaid.
More Than Half of Low- and Moderate-Income Adults Cannot Afford Their Deductibles
One-fifth of adults with health insurance spent at least 5% of their income on out-of-pocket healthcare costs over the past year with low-income adults the most likely to have high costs, according to a report from The Commonwealth Fund.
PNAS Study Details ZMapp Mechanism Against Ebola
ZMapp, which has been developed by Mapp Biopharmaceutical, was successful in 5 of 7 Ebola-infected patients; but the mechanism of it's action in those patients was not very clear.
USC Study Identifies Pollution as a Risk Factor for Obesity
The study, published in Environmental Health Perspectives, studied the BMI of children in Southern California over a period of 8 years, and studied it's correlation with environmental pollutants.
Merck’s Vytorin Achieves Primary, Secondary Endpoints in IMPROVE-IT Study
Patients taking Merck’s Vytorin, which combines simvastatin with the non-statin Zetia, experienced fewer major cardiovascular events than patients treated with simvastatin alone, according to the results of the IMPROVE-IT study.
Tumor Treating Fields Can Halt Glioblastomas
An electrical device glued to the scalp can slow cancer growth and prolong survival in people with the deadliest type of brain tumor, researchers reported on Saturday in Miami, at a meeting of the Society for Neuro-Oncology.
Healthcare Leaders Pursuing Telemedicine Adoption Despite Challenges
Despite challenges with reimbursement and physician buy-in, healthcare organizations are committed to implementing telemedicine programs, according to a survey of healthcare leaders, mostly C-suite executives.
Merck's Immuno-Oncology Molecule to Be Supported by Pfizer
The collaboration between the 2 drug giants will prove a big boost to Merck's cancer immunotherapy MSB0010718C, and will also improve it's global oncology business.
AJMC Oncology Conference Helps Managed Care Stakeholders Do More for Patients Who Have Coverage, But Still Have Limits
At its third annual conference, Patient-Centered Oncology Care 2014, The American Journal of Managed Care addressed new challenges in cancer care: more patients have coverage, but they may be “underinsured” or barred from academic centers. Amid rising drug costs and regulations that threaten community practices, the head of the largest oncology organization outlined a path toward value-based reimbursement.
Nivolumab Presents Superior Survival Results in Phase 3 Melanoma Trials
In a press release based off-of results presented at the Society for Melanoma Research 2014 International Congress in Zurich, Switzerland, BMS announced results from phase 3 of the CheckMate-066 trial.
FDA Approves Avastin Plus Chemotherapy for Platinum-Resistant Ovarian Cancer
Genentech announced that Avastin has been approved to treated platinum-resistant ovarian cancer, inc combination with chemotherapy, which now expands Avastin's use to 6 tumor types.
Generics May Not Remain a "Cheaper Option," Study Finds
The study, published in NEJM, found that in addition to supply chain and manufacturing problems, lack of competition may be adding to their costs.
A New Glioblastoma Vaccine on the Horizon
Following encouraging results from a second phase of a phase 1 trial, the researchers have planned a second phase, to be initiated in January 2015. The vaccine will be administered to glioblastoma patients just before they begin chemotherapy.
Integrating Palliative Care Into Managed Care for the Good of Patients
Yesterday, speakers opened Patient-Centered Oncology Care, sponsored by The American Journal of Managed Care, with a discussion of how to bring palliative care into the mainstream in cancer care. While progress has been made, a cultural bias against discussion end-of-life issue remains an obstacle.
Smokers Know Tobacco Responsible for their Bladder Cancer, Study Discovers
A Kaiser Permanante study surveyed bladder cancer patients and found that current and former smokers were aware of a connection between smoking and their disease.
NICE Comes Back With a List of 40 Expensive Drugs to Be Reassessed
The cost-value discussion in oncology continues in Europe as NICE lists 40 drugs that it plans to reassess in terms of cost versus patient benefit.
Repeat Breast Surgeries an Unnecessary Burden on Patients, Survey Finds
A national survey published in JAMA Surgery identified too many repeat surgeries in women with breast cancer.
DC Appeals Court Pulls ACA Case From Schedule
Following the Supreme Court's decision to hear an appeal for the ACA subsidy lawsuit King v Burwell, a DC appeals court has halted work on a similar case it was reviewing.
Study Finds Continuity of Care Reduces Costs, Mortality, Morbidity
As cost containment becomes increasingly important in healthcare, the findings of a recent study in the Annals of Family Medicine on the impacts of continuity of care could have an impact on how healthcare systems deliver care.
Nearly Half of Uninsured Don’t Understand Basic Health Insurance Concepts
Although open enrollment for the Affordable Care Act’s insurance Marketplaces is almost here, a 10-question survey from Kaiser Family Foundation found that the health law’s target audience still struggles with understanding insurance coverage.
Study Points to Disparity in HPV Vaccine Uptake
At an ongoing AACR meeting on Health Disparities in cancer, researchers from the Gillings School of Global Public Health presented data showing HPV vaccine uptake among girls is lowest in states with the highest rates of cervical cancer.